Contains viable, selected strains of human adenovirus type 4 and human adenovirus type 7 prepared in human-diploid fibroblast cell cultures (strain wi-38); virus strains have not been attenuated; cells are grown and the virus growth maintained in dulbecco's modified eagle's medium, fetal bovine serum, and sodium bicarbonate; approved for use in military populations 17-50 years of age; indicated for active immunization for the prevention of febrile acute respiratory disease caused by adenovirus type 4 and type 7; carton consists of one bottle of 100 tablets adenovirus type 4 (ndc 51285-174-02) and one bottle of 100 tablets adenovirus type 7 (ndc 51285-175-02); store refrigerated between 2-8 degrees c (35-46 degrees f); do not freeze; keep bottle tightly closed and protect from moisture; do not remove desiccant canister from bottle; prescription only; for oral administration; dosage: one tablet of adenovirus type 4 component and one tablet of adenovirus type 7 component
NSN 5960-01-380-0885
NSN 6650-01-578-8176
NSN 5950-01-577-0001
NSN 5996-01-400-3558
NSN 5985-00-319-5826
NSN 5905-01-600-3189
NSN 5925-01-214-3228
NSN 5915-00-053-2003
NSN 6110-01-517-4995
NSN 5985-01-190-9001
NSN 5915-00-324-2985
NSN 6320-00-809-5744